Some Aspects of the Pharmacology of β-Adrenoreceptor Blockers View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1976-06

AUTHORS

B. Åblad, E. Carlsson, C. Dahlöf, L. Ek

ABSTRACT

The pharmacodynamic properties of a β-blocker are mainly determined by its affinity to β1 andβ2-receptors respectively and by its intrinsic activity. It is suggested that there is no absolute organ separation of the two receptor sub-types. Instead bothβ1 andβ2 -receptors are involved in the mediation of the same effect. The frequency distribution ratio of β1/β2-receptors varies markedly among various effector responses.A non-selective and aβ1-selective blocker may have different haemodynamic effects when the levels of circulating adrenaline are high, because of their markedly different potency in inhibiting theβ2-mediated vasodilator effect of adrenaline. Data are presented which suggest the existence of a presynapticβ1 -receptor mediating a positive feedback mechanism on neuronal release of noradrenaline. More... »

PAGES

100-111

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/00003495-197600111-00025

DOI

http://dx.doi.org/10.2165/00003495-197600111-00025

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045796379

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/6242


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic beta-Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dogs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Vitro Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neurons", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Norepinephrine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organ Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propanolamines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propranolol", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Research Laboratories, AB Hassle, Fack, S-431 20, M\u00f6lndal 1, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.418151.8", 
          "name": [
            "Research Laboratories, AB Hassle, Fack, S-431 20, M\u00f6lndal 1, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "\u00c5blad", 
        "givenName": "B.", 
        "id": "sg:person.0104110465.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0104110465.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Laboratories, AB Hassle, Fack, S-431 20, M\u00f6lndal 1, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.418151.8", 
          "name": [
            "Research Laboratories, AB Hassle, Fack, S-431 20, M\u00f6lndal 1, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carlsson", 
        "givenName": "E.", 
        "id": "sg:person.01241360237.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241360237.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Laboratories, AB Hassle, Fack, S-431 20, M\u00f6lndal 1, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.418151.8", 
          "name": [
            "Research Laboratories, AB Hassle, Fack, S-431 20, M\u00f6lndal 1, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dahl\u00f6f", 
        "givenName": "C.", 
        "id": "sg:person.01030042415.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030042415.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Laboratories, AB Hassle, Fack, S-431 20, M\u00f6lndal 1, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.418151.8", 
          "name": [
            "Research Laboratories, AB Hassle, Fack, S-431 20, M\u00f6lndal 1, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ek", 
        "givenName": "L.", 
        "id": "sg:person.053714324.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.053714324.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00003495-197407010-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021418726", 
          "https://doi.org/10.2165/00003495-197407010-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00501004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022302262", 
          "https://doi.org/10.1007/bf00501004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00422805", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008705848", 
          "https://doi.org/10.1007/bf00422805"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/214597a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040361105", 
          "https://doi.org/10.1038/214597a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1976-06", 
    "datePublishedReg": "1976-06-01", 
    "description": "The pharmacodynamic properties of a \u03b2-blocker are mainly determined by its affinity to \u03b21 and\u03b22-receptors respectively and by its intrinsic activity. It is suggested that there is no absolute organ separation of the two receptor sub-types. Instead both\u03b21 and\u03b22 -receptors are involved in the mediation of the same effect. The frequency distribution ratio of \u03b21/\u03b22-receptors varies markedly among various effector responses.A non-selective and a\u03b21-selective blocker may have different haemodynamic effects when the levels of circulating adrenaline are high, because of their markedly different potency in inhibiting the\u03b22-mediated vasodilator effect of adrenaline. Data are presented which suggest the existence of a presynaptic\u03b21 -receptor mediating a positive feedback mechanism on neuronal release of noradrenaline.", 
    "genre": "article", 
    "id": "sg:pub.10.2165/00003495-197600111-00025", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1084788", 
        "issn": [
          "0012-6667", 
          "1179-1950"
        ], 
        "name": "Drugs", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "different haemodynamic effects", 
      "\u03b2-adrenoreceptor blocker", 
      "haemodynamic effects", 
      "vasodilator effect", 
      "neuronal release", 
      "effector responses", 
      "pharmacodynamic properties", 
      "\u03b2-blockers", 
      "different potencies", 
      "blockers", 
      "adrenaline", 
      "\u03b21", 
      "same effect", 
      "noradrenaline", 
      "intrinsic activity", 
      "positive feedback mechanism", 
      "receptors", 
      "pharmacology", 
      "effect", 
      "potency", 
      "feedback mechanism", 
      "release", 
      "response", 
      "levels", 
      "activity", 
      "mechanism", 
      "affinity", 
      "mediation", 
      "data", 
      "ratio", 
      "aspects", 
      "distribution ratio", 
      "existence", 
      "properties", 
      "separation", 
      "organ separation"
    ], 
    "name": "Some Aspects of the Pharmacology of \u03b2-Adrenoreceptor Blockers", 
    "pagination": "100-111", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045796379"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/00003495-197600111-00025"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "6242"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/00003495-197600111-00025", 
      "https://app.dimensions.ai/details/publication/pub.1045796379"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_114.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.2165/00003495-197600111-00025"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00003495-197600111-00025'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00003495-197600111-00025'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00003495-197600111-00025'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00003495-197600111-00025'


 

This table displays all metadata directly associated to this object as RDF triples.

182 TRIPLES      21 PREDICATES      78 URIs      66 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/00003495-197600111-00025 schema:about N0d8d8153ef64466388583e3a8ca3f048
2 N39cc3b2f90734512ac2cd9d423cbc1ed
3 N42ad1b0eed4e4809931a7f38bc021059
4 N4a440f2f0177484cb2f1370ce94aa8b5
5 N4cc1318fd53240218774f82525e8879d
6 N736ed24c7f174a909ddea7b342b05ea1
7 N8884d4544e824a018a7c888e1cb573b0
8 N9947b0e81ad74e8eb6d2997ed3594bd8
9 Na1a5993ef0b74683be6a6d163a77f3d0
10 Nb18e7d173b7947c19e667d99f75ca3d4
11 Ne02a87cfa1124d5782d2a1dec9d44735
12 Nef24863484ac4d34a8b5603b46e9d1d8
13 anzsrc-for:11
14 anzsrc-for:1115
15 schema:author Nbe65c30689584ae1b3a1dd841369300a
16 schema:citation sg:pub.10.1007/bf00422805
17 sg:pub.10.1007/bf00501004
18 sg:pub.10.1038/214597a0
19 sg:pub.10.2165/00003495-197407010-00002
20 schema:datePublished 1976-06
21 schema:datePublishedReg 1976-06-01
22 schema:description The pharmacodynamic properties of a β-blocker are mainly determined by its affinity to β1 andβ2-receptors respectively and by its intrinsic activity. It is suggested that there is no absolute organ separation of the two receptor sub-types. Instead bothβ1 andβ2 -receptors are involved in the mediation of the same effect. The frequency distribution ratio of β1/β2-receptors varies markedly among various effector responses.A non-selective and aβ1-selective blocker may have different haemodynamic effects when the levels of circulating adrenaline are high, because of their markedly different potency in inhibiting theβ2-mediated vasodilator effect of adrenaline. Data are presented which suggest the existence of a presynapticβ1 -receptor mediating a positive feedback mechanism on neuronal release of noradrenaline.
23 schema:genre article
24 schema:isAccessibleForFree false
25 schema:isPartOf N255a9b55713f49d981c44ec3602f1dd7
26 Nff11982749ec40bf8b3b4689db7592da
27 sg:journal.1084788
28 schema:keywords activity
29 adrenaline
30 affinity
31 aspects
32 blockers
33 data
34 different haemodynamic effects
35 different potencies
36 distribution ratio
37 effect
38 effector responses
39 existence
40 feedback mechanism
41 haemodynamic effects
42 intrinsic activity
43 levels
44 mechanism
45 mediation
46 neuronal release
47 noradrenaline
48 organ separation
49 pharmacodynamic properties
50 pharmacology
51 positive feedback mechanism
52 potency
53 properties
54 ratio
55 receptors
56 release
57 response
58 same effect
59 separation
60 vasodilator effect
61 β-adrenoreceptor blocker
62 β-blockers
63 β1
64 schema:name Some Aspects of the Pharmacology of β-Adrenoreceptor Blockers
65 schema:pagination 100-111
66 schema:productId N2a75550e355e4c61a7f6ed58f17bad6a
67 N2fa22e6d0c6746fc8c7b86a35cf21713
68 N56d592febda04ad680faa61e1b89dc4b
69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045796379
70 https://doi.org/10.2165/00003495-197600111-00025
71 schema:sdDatePublished 2022-09-02T15:44
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher N0599a619bcc04d14b2de2d93e4e03e8c
74 schema:url https://doi.org/10.2165/00003495-197600111-00025
75 sgo:license sg:explorer/license/
76 sgo:sdDataset articles
77 rdf:type schema:ScholarlyArticle
78 N046a0b0644474214a4dd0d44b3e294a9 rdf:first sg:person.01030042415.05
79 rdf:rest N2d8efad2e1ed405986073cc87235921e
80 N0599a619bcc04d14b2de2d93e4e03e8c schema:name Springer Nature - SN SciGraph project
81 rdf:type schema:Organization
82 N0d8d8153ef64466388583e3a8ca3f048 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Humans
84 rdf:type schema:DefinedTerm
85 N255a9b55713f49d981c44ec3602f1dd7 schema:issueNumber Suppl 1
86 rdf:type schema:PublicationIssue
87 N2a75550e355e4c61a7f6ed58f17bad6a schema:name doi
88 schema:value 10.2165/00003495-197600111-00025
89 rdf:type schema:PropertyValue
90 N2d8efad2e1ed405986073cc87235921e rdf:first sg:person.053714324.25
91 rdf:rest rdf:nil
92 N2fa22e6d0c6746fc8c7b86a35cf21713 schema:name pubmed_id
93 schema:value 6242
94 rdf:type schema:PropertyValue
95 N39cc3b2f90734512ac2cd9d423cbc1ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Propanolamines
97 rdf:type schema:DefinedTerm
98 N42ad1b0eed4e4809931a7f38bc021059 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Organ Specificity
100 rdf:type schema:DefinedTerm
101 N4a440f2f0177484cb2f1370ce94aa8b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Norepinephrine
103 rdf:type schema:DefinedTerm
104 N4cc1318fd53240218774f82525e8879d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Propranolol
106 rdf:type schema:DefinedTerm
107 N56d592febda04ad680faa61e1b89dc4b schema:name dimensions_id
108 schema:value pub.1045796379
109 rdf:type schema:PropertyValue
110 N607893cf7eec46e9b4657103f85136df rdf:first sg:person.01241360237.95
111 rdf:rest N046a0b0644474214a4dd0d44b3e294a9
112 N736ed24c7f174a909ddea7b342b05ea1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Cats
114 rdf:type schema:DefinedTerm
115 N8884d4544e824a018a7c888e1cb573b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name In Vitro Techniques
117 rdf:type schema:DefinedTerm
118 N9947b0e81ad74e8eb6d2997ed3594bd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Adrenergic beta-Antagonists
120 rdf:type schema:DefinedTerm
121 Na1a5993ef0b74683be6a6d163a77f3d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Animals
123 rdf:type schema:DefinedTerm
124 Nb18e7d173b7947c19e667d99f75ca3d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Dogs
126 rdf:type schema:DefinedTerm
127 Nbe65c30689584ae1b3a1dd841369300a rdf:first sg:person.0104110465.89
128 rdf:rest N607893cf7eec46e9b4657103f85136df
129 Ne02a87cfa1124d5782d2a1dec9d44735 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Hemodynamics
131 rdf:type schema:DefinedTerm
132 Nef24863484ac4d34a8b5603b46e9d1d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Neurons
134 rdf:type schema:DefinedTerm
135 Nff11982749ec40bf8b3b4689db7592da schema:volumeNumber 11
136 rdf:type schema:PublicationVolume
137 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
138 schema:name Medical and Health Sciences
139 rdf:type schema:DefinedTerm
140 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
141 schema:name Pharmacology and Pharmaceutical Sciences
142 rdf:type schema:DefinedTerm
143 sg:journal.1084788 schema:issn 0012-6667
144 1179-1950
145 schema:name Drugs
146 schema:publisher Springer Nature
147 rdf:type schema:Periodical
148 sg:person.01030042415.05 schema:affiliation grid-institutes:grid.418151.8
149 schema:familyName Dahlöf
150 schema:givenName C.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030042415.05
152 rdf:type schema:Person
153 sg:person.0104110465.89 schema:affiliation grid-institutes:grid.418151.8
154 schema:familyName Åblad
155 schema:givenName B.
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0104110465.89
157 rdf:type schema:Person
158 sg:person.01241360237.95 schema:affiliation grid-institutes:grid.418151.8
159 schema:familyName Carlsson
160 schema:givenName E.
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241360237.95
162 rdf:type schema:Person
163 sg:person.053714324.25 schema:affiliation grid-institutes:grid.418151.8
164 schema:familyName Ek
165 schema:givenName L.
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.053714324.25
167 rdf:type schema:Person
168 sg:pub.10.1007/bf00422805 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008705848
169 https://doi.org/10.1007/bf00422805
170 rdf:type schema:CreativeWork
171 sg:pub.10.1007/bf00501004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022302262
172 https://doi.org/10.1007/bf00501004
173 rdf:type schema:CreativeWork
174 sg:pub.10.1038/214597a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040361105
175 https://doi.org/10.1038/214597a0
176 rdf:type schema:CreativeWork
177 sg:pub.10.2165/00003495-197407010-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021418726
178 https://doi.org/10.2165/00003495-197407010-00002
179 rdf:type schema:CreativeWork
180 grid-institutes:grid.418151.8 schema:alternateName Research Laboratories, AB Hassle, Fack, S-431 20, Mölndal 1, Sweden
181 schema:name Research Laboratories, AB Hassle, Fack, S-431 20, Mölndal 1, Sweden
182 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...